share_log

GreenLight Biosciences Says Rwanda FDA Gave Regulatory Approval To Start Phase I/II Clinical Trial Of COVID-19 Vaccine Candidate

Benzinga Real-time News ·  Feb 1, 2023 07:27
GreenLight Biosciences Says Rwanda FDA Gave Regulatory Approval To Start Phase I/II Clinical Trial Of COVID-19 Vaccine Candidate
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment